Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Simon Cork

New daily pill may help people keep weight off after stopping jabs

Orforglipron works by lowering blood sugar levels, slowing food digestion and reducing appetite

The Independent UK

Weight-loss jabs linked to hundreds of cases of life-threatening illness and 10 deaths

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute and chronic pancreatitis among people taking them, figures from the UK’s medicines regulator reveal

The Independent UK

Weight loss jabs could impact your contraception. Here’s why

ANALYSIS: Simon Cork on the surprising side effect of weight loss jabs - unintended pregnancy

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Experts warn that weight-loss jabs may need to be taken for life

Experts said the jabs should not be seen as the first option in weight loss

The Independent UK

Weight-loss jabs may need to be taken for life, experts warn

Professor Graham Easton said much like blood pressure drugs, ‘if you want lifelong effects, you have to keep on them lifelong’.

Evening Standard

People using drug Mounjaro sustain weight loss over three years, trial finds

Study into medication known as ‘King Kong’ of weight loss drugs throws fresh light on effects of longer-term use

The Guardian - UK

How does weight loss drug Mounjaro work and why is it in such high demand?

The ‘King Kong of weight loss drugs’ will be available on the NHS but only patients with most need will get it

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Weight loss jabs not ‘quick fix’ for UK worklessness, health experts warn

Scientists say using the drugs to get people back into work could carry logistical and ethical problems

The Guardian - UK

‘Skinny jabs’: weight-loss drugs set for new boom as generic versions emerge

Alternatives to costly Wegovy and Saxenda will make such treatments more widely available worldwide

The Guardian - UK

Wednesday briefing: The study that says semaglutide can do much more than help you lose weight

In today’s newsletter: A new study suggests semaglutides reduce not just obesity but risks to your heart too. What will that mean for their availability on the NHS?

The Guardian - UK

Don’t use weight-loss jabs to counter Christmas indulgence, warn experts

Exclusive: Doctors, psychologists and campaigners say the diabetes drugs are not appropriate for everyone

The Guardian - UK

Weight-loss jabs linked to ‘severe’ stomach problems – study

Researchers said instances were ‘rare’ but hundreds of thousands of people could still be affected due to the drugs’ popularity globally.

The Independent UK

‘Game changer’ weight loss jab to become available on NHS

Experts described the move as a ‘pivotal moment’ for the treatment of people living with obesity.

The Independent UK

Man transforms his shed into a bar fit for a night out

Simon Cork from Cheshire turned his pub into The Popped Cork during the Covid lockdown

Wales Online

Get all your
news in one place.

100's of premium titles.
One news app.

Manchester Evening News

The shed at the bottom of one man's garden that's a great night out

It started out as decking... now it's a 'haven of fun'

Inverse

Do vagus nerve exercises help anxiety? Murky science complicates a wellness trend

The vagus nerve is an exciting target in the world of science and a darling in the wellness industry. But the science surrounding it is complicated.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Anglia Ruskin University

31 stories

the National Institute for Health and Care Excellence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.